COVID-19 THERAPEUTICS ACCELERATOR
COVID-19 Therapeutics Accelerator is a philanthropic collaboration supporting efforts to research, develop and bring effective treatments.
COVID-19 THERAPEUTICS ACCELERATOR
Status:
Active
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API LetsEncrypt Google Tag Manager WordPress Wordpress Plugins Sitelinks Search Box Yoast WordPress SEO Plugin Yoast SEO Premium
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2021-12-07 | Sosei Group | COVID-19 Therapeutics Accelerator investment in Grant - Sosei Group | N/A |
More informations about "COVID-19 Therapeutics Accelerator"
Frequently Asked Questions - COVID-19 Therapeutics Accelerator
The COVID-19 Therapeutics Accelerator (CTA) was launched in March 2020 by Wellcome Trust, the Bill & Melinda Gates Foundation and Mastercard, with additional funding from a range of โฆSee details»
The Access to COVID-19 Tools (ACT) Accelerator
The Access to COVID-19 Tools (ACT) Accelerator, is a new, groundbreaking global collaboration to accelerate development, production, and equitable access to COVID-19 tests, treatments, and vaccines. ... ACT-Accelerator Facilitation โฆSee details»
ACT-Accelerator FAQ - World Health Organization (WHO)
The Access to COVID-19 Tools (ACT) Accelerator is the worldโs most comprehensive end-to-end solution to ending the acute phase of the devastating COVID-19 pandemic. It brings together โฆSee details»
COVID-19 Therapeutics Accelerator | World Economic โฆ
The COVID-19 Therapeutics Accelerator will work with the World Health Organization, government and private sector funders and organizations, as well as the global regulatory and policy-setting institutions. The Accelerator will โฆSee details»
COVID-19 Therapeutics Accelerator - Bill & Melinda Gates โฆ
The COVID-19 Therapeutics Accelerator will work with the World Health Organization, government and private sector funders and organizations, as well as the global regulatory and โฆSee details»
Investments Made - COVID-19 Therapeutics Accelerator
Investments Made. As of October 26th, 2020, the COVID-19 Therapeutics Accelerator has awarded over $98 million in grants.See details»
ACT-A HSRC - World Health Organization
The Access to COVID-19 Tools Accelerator (ACT-A) is a global collaboration to accelerate the development, production, and equitable access to COVID-19 tools (diagnostics, therapeutics, โฆSee details»
Announcing the COVID-19 Therapeutics Accelerator
Mar 8, 2020 Mark Suzman announces the COVID-19 Therapeutics Accelerator, a partnership between the Bill & Melinda Gates Foundation, Wellcome, and Mastercard. The initiative aims to identify potential treatments for COVID-19, โฆSee details»
Unitaid and the access to COVID-19 tools accelerator
Jul 3, 2020 The urgent need for effective tools to limit the damage of COVID-19. The Access to COVID-19 Tools (ACT) Accelerator was launched in April 2020 by the World Health Organization and a range of global partners. The aim of this โฆSee details»
ACT-Accelerator update - World Health Organization โฆ
Jun 26, 2020 The therapeutics pillar is led by Unitaid and the Wellcome Trust (on behalf of the COVID-19 Therapeutics Accelerator) and seeks to accelerate the development and equitable delivery of treatments at all stages of disease, โฆSee details»
COVID-19 Therapeutics Accelerator | Most Influential Projects
For letting the science lead the funding on potential COVID-19 treatments. Backed by major players ranging from Mastercard to The Bill & Melinda Gates Foundation to Wellcome, the โฆSee details»
Propose a Treatment or Study - COVID-19 Therapeutics Accelerator
The COVID-19 Therapeutics Accelerator has prioritized proposals based on the following scoping criteria. Solutions should have suitability for low-resource settings, with global access through โฆSee details»
Investing in COVID-19 Treatments - Bill & Melinda Gates Foundation
Apr 29, 2020 Trevor Mundel, President of the Bill & Melinda Gates Foundation's Global Health division, provides an update on the COVID-19 Therapeutics Accelerator. The Accelerator was โฆSee details»
COVID Moonshot funded by COVID-19 Therapeutics Accelerator โฆ
Sep 27, 2021 The COVID Moonshot, a non-profit, open-science consortium of scientists from around the world dedicated to the discovery of globally affordable and easily-manufactured โฆSee details»
FUJIFILM Diosynth Biotechnologies Stands Ready to Manufacture โฆ
HILLERØD, Denmark โ FUJIFILM Diosynth Biotechnologies, a world leading Contract Development and Manufacturing Organization (CDMO) for biologics, viral vaccines and viral โฆSee details»
CTA Donors - COVID-19 Therapeutics Accelerator
Founding and Core Donors Partnership is more important now than ever before. The Bill & Melinda Gates Foundation, Wellcome Trust, and Mastercard each committed seed funding to โฆSee details»
COVID-19 Therapeutics Accelerator Donors Launch International โฆ
The COVID-19 Therapeutics Accelerator will play a catalytic role by accelerating and evaluating new and repurposed drugs and biologics to treat patients with COVID-19 in the immediate โฆSee details»
Coronavirus Treatment Acceleration Program (CTAP) | FDA
The development of COVID-19 therapeutics that are effective against current and future variants remains a critical priority. CTAP today remains vital to the expedited development of COVID-19 ...See details»
Therapeutics Accelerator Update - Bill & Melinda Gates Foundation
Apr 2, 2020 Itโs been about three weeks since the foundation announced the COVID-19 Therapeutics Accelerator. What progress has been made? Yes. Thereโs been a lot of โฆSee details»